Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) was upgraded by stock analysts at Roth Capital to a “strong-buy” rating in a report released on Tuesday, Zacks reports.
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Rapid Micro Biosystems presently has an average rating of “Moderate Buy” and a consensus target price of $5.00.
Read Our Latest Stock Analysis on RPID
Rapid Micro Biosystems Stock Down 1.4%
Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) last issued its earnings results on Friday, August 7th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.03). The firm had revenue of $8.05 million during the quarter, compared to analyst estimates of $7.88 million. Rapid Micro Biosystems had a negative net margin of 145.56% and a negative return on equity of 177.04%. Sell-side analysts anticipate that Rapid Micro Biosystems will post -0.91 earnings per share for the current year.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of RPID. Bank of America Corp DE grew its position in shares of Rapid Micro Biosystems by 139.9% in the first quarter. Bank of America Corp DE now owns 31,014 shares of the company’s stock valued at $70,000 after purchasing an additional 18,085 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Rapid Micro Biosystems by 9.5% in the 1st quarter. Renaissance Technologies LLC now owns 126,617 shares of the company’s stock valued at $287,000 after buying an additional 10,990 shares in the last quarter. Sei Investments Co. lifted its holdings in shares of Rapid Micro Biosystems by 204.2% during the first quarter. Sei Investments Co. now owns 284,816 shares of the company’s stock worth $647,000 after buying an additional 191,200 shares in the last quarter. Temasek Holdings Private Ltd bought a new stake in shares of Rapid Micro Biosystems in the first quarter valued at about $50,000. Finally, Dimensional Fund Advisors LP grew its stake in shares of Rapid Micro Biosystems by 55.9% in the first quarter. Dimensional Fund Advisors LP now owns 87,589 shares of the company’s stock valued at $199,000 after acquiring an additional 31,407 shares in the last quarter. 52.60% of the stock is owned by institutional investors.
Rapid Micro Biosystems Company Profile
Rapid Micro Biosystems, Inc develops automated solutions for detecting and monitoring microbial contamination in pharmaceutical, biotechnology, and other regulated manufacturing environments. Its technologies are designed to help companies replace or reduce manual, labor-intensive microbiological testing processes while supporting quality control and regulatory compliance.
The company’s primary offering is the Growth Direct platform, an automated microbial detection system that combines instrumentation, consumables, and software.
See Also
- Five stocks we like better than Rapid Micro Biosystems
- Bitcoin Is Bouncing Back—Here are 2 Ways to Play the Rebound
- The Bull Case for Amprius Technologies Just Got Stronger
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
